News and press releases
Neuro Event Labs Announced MedTech Veteran Rod Williams as CEO for NEL Inc.
Neuro Event Labs is a leading AI Motion Diagnostics and Digital Health company. Neuro Event Labs is happy to announce a strategy change toward worldwide development with the appointment of Rodney (Rod) J. Williams as Chief Executive Officer of Neuro Event Labs, Inc., the company’s U.S. subsidiary. Nelli® has been granted Breakthrough Device Designation by the FDA and is an investigational device in the USA.
14th European Epilepsy Congress
Palexpo, Geneva, Switzerland Saturday 9th July 2022 to Wednesday 13th July 2022 Neuro Event Labs is happy to announce that we will be attending the 14th European Epilepsy Congress (EEC) (formerly European Congress on Epileptology or ECE) organised by International League Against Epilepsy (ILAE). This event will take place from 9 - 13 July 2022 at Palexpo, Geneva, Switzerland.
Neuro Event Labs at AES 2021, Chicago, IL
The American Epilepsy Society’s Annual Meeting is the largest gathering on epilepsy in the world. Meet Neuro Event Labs at Booth #1725 where we can give you a personal live demo and answer any questions you might have. December 3-7 Booth 1725, McCormick Place – West Building, Chicago, IL We have 5 NEL members attending over the course of the meeting who all look forward to welcoming you.
3rd International Congress on Mobile Devices and Seizure Detection in Epilepsy
Copenhagen, Denmark October 28 - 30, 2021 Come visit us at Stand 9 in the main hall where we can give you a personal live demo and answer any questions you might have. We have 6 NEL members attending over the course of the congress who all look forward to welcoming you!
Neuro Event Labs signs contract with Filadelfia Epilepsy Hospital in Denmark to implement the Nelli Pro in hospital AI powered monitoring of patients across all patient beds.
Neuro Event Labs is proud to announce that it has signed a partnership agreement with Filadelfia Epilepsy Hospital in Dianalund, Denmark for the implementation of the Nelli Pro monitoring system. The contract covers the implementation and usage of Nelli Pro across all 46 hospital beds at Dianalund for pediatric, adult and epilepsy monitoring units.
Neuro Event Labs Receives FDA Breakthrough Device Designation for Nelli®, the World’s First Automated Video and Audio-Based Seizure Monitoring System
Neuro Event Labs, a global diagnostic company, announced that Nelli® received a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The system is designed to automate the identification of seizure events using video, audio and sophisticated software algorithms using artificial intelligence (AI). This is the first Breakthrough Device designation for a seizure diagnostic monitoring system.
€1.9M EU funding takes Nelli® available for all epilepsy patients
Neuro Event Labs (NEL) will use €1.9M EU Horizon 2020 grant to become the standard of care in epilepsy diagnostics. The competitive EU Horizon 2020 grant was only awarded to 1,4% of applicants. The jury highlighted the novelty, clear unmet need in the market, timing, and improvements over the current state of the art.
Neuro Event Labs closes €3.9M Series A round to become the standard for epilepsy diagnostics
Finnish Health Tech company Neuro Event Labs has raised €3.9 million from Hadean Ventures, SHS Capital and Maki.vc to support the commercial expansion of their lead product Nelli®. Neuro Event Labs offers significantly more personalized, accurate and scalable diagnostics to treat up to 65 million epilepsy patients worldwide, responding to the increased demand for remote healthcare solutions.
Neuro Event Labs signs strategic partnership with Jefferson Health to introduce AI neurology tool Nelli® in the United States
Neuro Event Labs’ AI tool Nelli® has the potential to improve treatment for thousands of patients suffering from epilepsy and other neurological conditions. JANUARY 31, 2020 Tampere, FIN; Philadelphia, USA: 31 January 2020: Neuro Event Labs Oy, the Finnish clinical AI technology company, announces today that it has signed a non-exclusive strategic partnership with Jefferson Health.
Nelli's data helped find the right treatment for Martta
Martta, 21, has epilepsy. As part of her treatment planning, she used the Nelli Home device from Neuro Event Labs. The device is designed for epilepsy monitoring at the patient’s own home. Nelli helped doctors find exactly the right treatment option for Martta, resulting in fewer night-time epilepsy seizures, for example.
Neuro Event Labs reduces guesswork in neurology
Neuro Event Labs’ CEO Kaapo Annala was interviewed by Good News In Finland, a journal dedicated to Finnish innovations and technologies. In this in-depth interview, Kaapo walks us through our innovation Nelli, technologies behind it and most importantly, how it helps doctors to provide better, individualized treatment of patients. Good News In Finland: Neuro Event Labs reduces guesswork in neurology
Meet Nelli at Exeter and Lausanne
Welcome to explore Nelli at Exeter, UK and Lausanne, Switzerland in September. Neuro Event Labs will participate next week in two congresses. International Conference for Technology & Analysis of Seizures will be held in University of Exeter in 2 - 6 September. We are in booth hosted by UCB and demonstrating clinical use of Nelli as part of epilepsy journey.
Artificial Intelligence Identifies Key Patterns From Video Footage Of Infant Movements
In cooperation with Helsinki University Hospital and University of Pisa, Neuro Event Labs has developed and proven a method to extract clinically useful information from infant videos to assess child’s neurodevelopment. In this peer-reviewed study, the method has been used in early identification of cerebral palsy (CP). Artificial Intelligence Identifies Key Patterns From Video Footage Of Infant Movements
Ministry of Economic Affairs highlights Neuro Event Labs as an AI Pioneer
In its recent report on Finland’s national Artificial Intelligence Programme, the Finnish Ministry of Economic Affairs and Employment introduces Neuro Event Labs as one of the leading companies utilizing AI. AI has been nationally recognized as one of the most important technologies of our time, capable of creating new economic growth and promoting wellbeing.
Working as a scientist in a technology startup
Here at Neuro Event Labs, we build a revolutionary product that helps people with epilepsy live better lives. In this blog post, I’ll briefly discuss the scientific part of our work and share my experiences of working as a scientist in a high-technology startup.
The Best AI Service in Finland, 2018
Last year at Slush, we demonstrated our AI-powered epilepsy monitoring service to a wider audience. Since then, we have doubled our efforts to provide a stronger and smarter deep learning system that can help neurologists to utilize the quantitative and objective data that we provide; something we already see providing better individualized treatment for patients with epilepsy.
Tampere 2018 Innovation Award
The Neuro Event Labs leadership team has been selected as the winner of the 2018 Tampere City Innovation Award. The selection committee highlighted the team’s innovative solution utilizing the latest computer vision and machine learning technologies, combining those technologies to solve real problems in epilepsy. Neuro Event Labs’ product, Nelli, helps doctors to better diagnose and monitor patients, especially in home environments as part of the patient’s normal life.
Press release: Neuro Event Labs receives new funding, joins 70 million euro Maki.vc investment fund
Neuro Event Labs has been selected in a new venture capital fund founded by leading Finnish technologists. The fund invests 500,000 Euros in the company. This complements an investment of 100,000 Euros by OmaMedical and 1.3 million Euros made by Business Finland, a Finnish national growth acceleration organization. The new fund being established, Maki․vc, will become a major Nordic venture capital fund with up to 70 million Euros (approx․ 86 million USD) total fund size.
NEL selected one of TOP-6 finalists at major epilepsy conference in San Francisco
Neuro Event Labs will be pitching our epilepsy treatment solution at the 2018 Epilepsy Pipeline Conference, organized in San Francisco on February 22-23, 2018. We are among the 6 finalists who take part in a Shark Tank competition, pitching our solution to live conference attendees and a panel of judges - or Sharks - representing corporate executives, investors, physicians and scientists, and people living with epilepsy.
NEL’s monitoring solution and VNS provide powerful results together
Tampere University Hospital (Tays), Neuro Event Labs’ key client, has been using our epilepsy monitoring solution together with a vagus nerve stimulator (VNS) to treat patients with epilepsy and to evaluate the effectiveness of the treatment. As part the cooperation, a Tays patient used NEL’s night-time epilepsy monitoring solution for a full month, right at the patient’s home.
Disruptive machine vision at Slush
Startups are all about disrupting the status quo - finding a superior, often a high-tech, solution to a problem and changing how the markets work. This week, the Neuro Event Labs team will be attending Slush, one of the biggest startup events in the world. At Slush, we will demo a key element of our solution: a machine vision sensor that detects even the tiniest of disruptions in a person’s breathing.
NEL triumphs in country-wide business competition
Neuro Event Labs’ CEO Kaapo Annala pitched this week in Finland’s biggest company growth challenge, Kasvu Open. After making it to the top-10 finale (out of 839 companies), Neuro Event Labs took second place in the start-up series, as well as being voted the “audience choice” in a landslide victory.
World-leading innovation in epilepsy with Tampere University Hospital
Tampere University Hospital has been one of our research partners since day one. Over the past 4 months, they’ve also expressed their gratitude as a happy customer. News of our cooperation can be found as an official press release, an article in the Finnish Medical Journal, and the Finnish Medical News (all articles in Finnish).
Getting help in the thought process
I am sitting in a classroom, asking myself if our business model is sound also in real world — and not only in Finland, but elsewhere in world. Just a moment ago I thought we had been considering our product and business model from every possible angle. Some moments later, I’d formed a totally new view of one of the hardest obstacles in Neuro Event Labs’ path, which opened a few new options to overcome a problem we hadn’t thought of earlier.
CE Marking of Medical Devices
The process for CE marking a medical device is a complicated landscape. In order to get an understanding of a process and find out what should be done, one encounters a significant amount of literature to process. Thankfully, there are people and services that can simplify this puzzle significantly. If you don’t want to read every page of every EU directive, their guidelines, hard-to-decipher pages of Finnish law, and make tens of phone calls just to understand how the actual process works, I can recommend some without hesitation.
Year of learning
During the first years of existence, for most startups, the product and idea are evolving a lot. Quite often the original idea is no longer alive, but dumbed down due to good reasons when developing the idea further. We have also been developing the original idea of the NeuroEventLabs product further, mostly as an effect of the learning process with customers.
People tend to say time flies, when you’re having fun. Well, that’s at least what has happened for us. All of a sudden, I realized it was already February and that it’s been months since the last post on the site… time to fix that. We had truly an amazing 2015; the product has evolved greatly and so have we.